SU2C Scientific Research Teams

Share this:
Like
Email

Like this page on Facebook

Joe W. Gray, Ph.D.

Scientific Research Team:
An Integrated Approach to Targeting Breast Cancer Molecular Subtypes and Their Resistance Phenotype

Joe W. Gray, Ph.D.

Joe W. Gray, Ph.D., has been director of the Division of Life Sciences and associate laboratory director for life and environmental sciences at Lawrence Berkeley National Laboratory since 2003. He is also an adjunct professor in the department of laboratory medicine at the University of California, San Francisco, School of Medicine, program co-leader of breast oncology at the UCSF Helen Diller Family Comprehensive Cancer Center, and sits on the National Cancer Institute Board of Scientific Advisors.

Gray received his engineering degree from the Colorado School of Mines in 1968 and his doctorate in physics from Kansas State University in 1972. The same year, he began research in the Biomedical Sciences Division of the Lawrence Livermore National Laboratory and became cytophysics section leader 10 years later. Gray joined UCSF as professor of laboratory medicine in 1991and held that position until 2003. He also served as director of resource for molecular cytogenetics at Lawrence Berkeley National Laboratory.

The Gray Laboratory at the Lawrence Berkeley National Laboratory explores mechanisms by which genomic, transcriptional and proteomic abnormalities occur in selected cancers, elucidates how these abnormalities contribute to cancer pathophysiology and assesses the ways in which these abnormalities influence responses to experimental therapies.

Gray has published his work in Cancer Research, Nature, Clinical Cancer Research, Cancer Cell and Science, among others. He has received numerous awards for his research including the E. O. Lawrence Award from the U.S. Department of Energy, the Curt Stern Award from the American Society for Human Genetics, a Distinguished Achievement Award from the Colorado School of Mines, an Alumni Fellow Award from Kansas State University, an honorary Doctor of Medicine from Tampere University, the Komen Foundation Brinker Award for Scientific Distinction and the 2008 Team Science Award from the American Association for Cancer Research.

Here we stand on the verge of unlocking the secrets that will end cancer. Donate Now.
A one percent reduction in cancer deaths would be worth $500 billion, almost 2.5 times what the U.S. spends each year on the disease.